ArticleInternational journal of molecular sciences2022

Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines.

Ya-Ting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.